Synthesis of HPMA Copolymers Containing Doxorubicin Bound via a Hydrazone Linkage. Effect of Spacer on Drug Release and in vitro Cytotoxicity

Abstract

Full Paper: The aim of this study was the synthesis, physico-chemical characterization and preliminary evaluation of biological activity of novel polymer drugs based on conjugates of anti-cancer drug doxorubicin (Dox) with water-soluble polymer drug carriers based on N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers. In the conjugates, Dox is attached to the polymer via a pH-sensitive linkage susceptible to hydrolysis at pH 5-6, thus enabling intracellular Dox release. Seven Dox-containing polymer conjugates differing in the length and structure of the single-amino-acid or oligopeptide spacer were synthesized (Gly, β-Ala, 6-aminohexanoyl, 4-aminobenzoyl, GlyGly, GlyLeuGly, Gly-DL-PheLeuGly) and the relationship between the spacer structure and the rate of in vitro Dox release was studied at various pH. The rate of Dox release at pH5 (close to lysosomal pH) ranged from 70 to 96% of total Dox/48 h, depending on the spacer structure and being the highest for the conjugate containing the 6 aminohexanoyl spacer. The rate of Dox release from most conjugates incubated at pH 7.4 (blood pH) was more than 10 times slower, ca. 4-10% of total Dox/48 h. Molecular weight of the polymer (25 000-115 000 g/mol) did not significantly influence the rate. The presence of lysosomal enzyme cathepsin B in incubation media increased the rate of Dox release from the conjugates with oligopeptide GlyLeuGly and Gly-DL-PheLeuGly spacers by 15-30%, whereas the release from conjugates with other spacers remained unchanged. Cytotoxicity of all hydrazone conjugates for mouse EL-4 T cell lymphoma cells was much higher and close to that of free Dox (IC 5 0 0.1-0.34 μg Dox/mL), in contrast to cytotoxicity of similar classic conjugates bearing Dox attached via an amide bond (IC 5 0 19 μg Dox/mL).